Blocking An Inflammation Pathway Prevents Cardiac Fibrosis, Could Lead To New Therape

New research from UC Davis published in the Proceedings of the National Academy of Sciences Led by Nipavan Chiamvimonvat, cardiologist and professor of internal medicine, a team of researchers tested a compound that inhibits the enzyme soluble epoxide hydrolase -- or sEH -- one of the key players in the robust immune-system response that heals tissue following an injury...

More...